Parallax Volatility Advisers
ALXN

Parallax Volatility Advisers’s Alexion Pharmaceuticals ALXN Stock Holding History

Parallax Volatility Advisers’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,400
Closed -$992K – 3665
2021
Q2 		$992K Buy
+5,400
New +$927K ﹤0.01% 1930
2021
Q1 		– Sell
-700
Closed -$110K – 3862
2020
Q4 		$110K Sell
700
-600
-46% -$77.1K ﹤0.01% 2927
2020
Q3 		$147K Sell
1,300
-41,500
-97% -$4.48M ﹤0.01% 2629
2020
Q2 		$4.8M Sell
42,800
-54,300
-56% -$5.76M 0.01% 1095
2020
Q1 		$8.72M Buy
97,100
+58,800
+154% +$5.77M 0.01% 658
2019
Q4 		$4.14M Buy
38,300
+26,400
+222% +$2.82M ﹤0.01% 975
2019
Q3 		$1.17M Buy
+11,900
New +$1.34M ﹤0.01% 1327
2018
Q4 		– Sell
-44,000
Closed -$6.12M – 4297
2018
Q3 		$6.12M Buy
+44,000
New +$5.52M 0.01% 643
2018
Q2 		– Sell
-5,000
Closed -$557K – 3649
2018
Q1 		$557K Hold
5,000
– – ﹤0.01% 1101
2017
Q4 		$598K Buy
+5,000
New +$609K ﹤0.01% 1417
2015
Q4 		– Sell
-25,000
Closed -$3.91M – 4187
2015
Q3 		$3.91M Hold
25,000
– – 0.01% 756
2015
Q2 		$4.52M Buy
+25,000
New +$4.31M 0.01% 747
2014
Q2 		– Sell
-107,500
Closed -$16.4M – 4379
2014
Q1 		$16.4M Buy
+107,500
New +$17.1M 0.1% 176

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Parallax Volatility Advisers's ALXN Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 19,394 shares — an estimated $3.56M sold.

Parallax Volatility Advisers first reported a position in ALXN in Q1 2014 and held it in 15 quarters. The position peaked at $6.46M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Parallax Volatility Advisers reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 19,394 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3.56M.
  • Parallax Volatility Advisers first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Parallax Volatility Advisers's Alexion Pharmaceuticals position peaked at $6.46M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.